SCHEMBL7035635

SCHEMBL7035635

COc1ccc(C(=O)c2ccc(Nc3cncc4ccccc34)cc2Cl)c(C)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 10/20 0.52
MAPK12 P53778 10/20 0.52
MAPK11 Q15759 10/20 0.52
MAPK14 Q16539 10/20 0.52
POLB P06746 3/20 0.46
MAPT P10636 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.41
TP53 P04637 1/20 0.41
CYP11B1 P15538 2/20 0.41
CYP11B2 P19099 2/20 0.41
CSF1R P07333 1/20 0.41
LMNA P02545 2/20 0.41
AKR1C3 P42330 1/20 0.41
AKR1C2 P52895 1/20 0.41
CYP17A1 P05093 1/20 0.41
ALDH1A1 P00352 1/20 0.41
ADRA2A P08913 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
ADRA1A P35348 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7035912 0.89 CYP11B1 (0.41) MAPK13MAPK12MAPK11MAPK14POLB
SCHEMBL7040319 0.89 MAPT (0.42) MAPK13MAPK12MAPK11MAPK14POLB
SCHEMBL7036407 0.88 MAPK14 (0.67) MAPK13MAPK12MAPK11MAPK14ADRA2A
SCHEMBL7039634 0.87 MAPK14 (0.54) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL7032158 0.87 MAPT (0.41) MAPK13MAPK12MAPK11MAPK14POLB
SCHEMBL7033606 0.86 MAPK13 (0.64) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL7036535 0.83 MAPK13 (0.55) MAPK13MAPK12MAPK11MAPK14ADRA2A
SCHEMBL7516429 0.81 MAPK13 (0.48) MAPK13MAPK12MAPK11MAPK14ADRA2A
SCHEMBL7039283 0.79 CYP11B1 (0.41) MAPTSMN1; SMN2TP53CYP11B1CYP11B2
SCHEMBL7080506 0.78 ADRA2A (0.43) MAPK13MAPK12MAPK11MAPK14ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289958-A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a) Leo Pharma A/S (DK) 2003-03-12 EP claimed
US-6432962-B2 Benzophenones as inhibitors of IL-1β and TNF-α LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-08-13 US claimed
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-02-07 US claimed
WO-2001090074-A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) LEO PHARMA A/S (DK) 2001-11-29 WO claimed
EP-1289958-A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a) Leo Pharma A/S (DK) 2003-03-12 EP disclosed
US-6432962-B2 Benzophenones as inhibitors of IL-1β and TNF-α LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-08-13 US disclosed
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-02-07 US disclosed
WO-2001090074-A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) LEO PHARMA A/S (DK) 2001-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha IL1B, IL1A, NFKBIA MAPK13 1908/4885MAPK12 1184/4885MAPK11 2116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.